Aarti Pharmalabs Board Meeting on Oct 28 for Q2 Results

Aarti Pharmalabs Ltd has announced that its Board of Directors will convene on October 28, 2026. The primary agenda item is the consideration and approval of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting will also include the review of the Limited Review Reports from the auditors for the same period. In line with SEBI regulations and the company's insider trading code, the trading window for securities will remain closed from October 1, 2026, until October 30, 2026, to prevent any potential misuse of information related to the financial results.